
    
      Investigational product

        -  baseline: Vortioxetine 10mg (or placebo) qd + Acamprosate*

        -  First 2 weeks: Vortioxetine 5-10mg (or placebo) qd+ Acamprosate*

        -  Last 6 weeks: Vortioxetine 5-20mg (or placebo) qd + Acamprosate*

             -  Acamprosate 666 mg bid for bodyweight < 60 kg; Acamprosate 666 mg tid for
                bodyweight â‰¥ 60 kg
    
  